These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 18216583

  • 1. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD, Goldman D, Ide T, Yoo SH.
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [Abstract] [Full Text] [Related]

  • 2. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L, Barkana Y, Iskhakov V, Rayvich S, Gerber Y, Morad Y, Avni I, Zadok D.
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y, Sakarya R.
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [Abstract] [Full Text] [Related]

  • 4. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
    García DP, Alperte JI, Cristóbal JA, Mateo Orobia AJ, Muro EM, Valyi Z, Del Rio BJ, Arnao MR.
    Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD, Kankariya VP, Kontadakis GA.
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y.
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [Abstract] [Full Text] [Related]

  • 8. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM, Reitamo S, Kari M, Kari O.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH, Utine CA, Stern ME, Akpek EK.
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y, Yamamoto T, Isobe T, Kusunoki T, Tsuboi R.
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
    Kroft EB, Erceg A, Maimets K, Vissers W, van der Valk PG, van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
    [Abstract] [Full Text] [Related]

  • 14. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis.
    Stumpf T, Luqmani N, Sumich P, Cook S, Tole D.
    Cornea; 2006 Dec; 25(10):1147-9. PubMed ID: 17172887
    [Abstract] [Full Text] [Related]

  • 15. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA, Kaufman HE, Insler M.
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [Abstract] [Full Text] [Related]

  • 16. Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment.
    Kymionis GD, Klados NE, Kontadakis GA, Mikropoulos DG.
    Cornea; 2013 Nov; 32(11):1499-501. PubMed ID: 23770977
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of tracrolimus 0.1% ointment in prurigo].
    Lee HH, Sterry W, Worm M.
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):690-4. PubMed ID: 16173976
    [Abstract] [Full Text] [Related]

  • 18. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [Abstract] [Full Text] [Related]

  • 19. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US Tacrolimus Ointment Study Group.
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [Abstract] [Full Text] [Related]

  • 20. Topical tacrolimus in the treatment of localized scleroderma.
    Mancuso G, Berdondini RM.
    Eur J Dermatol; 2003 Dec; 13(6):590-2. PubMed ID: 14721783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.